The American Diabetes Association’s new consensus highlights that liver disease has been underrecognized in people with prediabetes and type 2 diabetes, despite very high overlap with metabolic dysfunction–associated steatotic liver disease (MASLD).
Read More> https://pocncoe.com/diabetes/home/article/dont-miss-masld-in-diabetesscreen-early-prevent-cirrhosis/